Cargando…
Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide
GLP-1 receptor agonists are a class of diabetes medicines offering self-regulating glycemic efficacy and may best be administrated in long-acting forms. Among GLP-1 receptor agonists, exenatide is the one requiring the least dose so that controlled-release poly(d,l-lactic-co-glycolic acid) (PLGA) mi...
Autores principales: | Ge, Yuxuan, Hu, Zhenhua, Chen, Jili, Qin, Yujie, Wu, Fei, Jin, Tuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226777/ https://www.ncbi.nlm.nih.gov/pubmed/34070856 http://dx.doi.org/10.3390/pharmaceutics13060816 |
Ejemplares similares
-
Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release
por: Dong, Ni, et al.
Publicado: (2020) -
Oral Delivery of Exenatide via Microspheres Prepared by Cross-Linking of Alginate and Hyaluronate
por: Zhang, Baojie, et al.
Publicado: (2014) -
Effect of Stabilizers on Encapsulation Efficiency and Release Behavior of Exenatide-Loaded PLGA Microsphere Prepared by the W/O/W Solvent Evaporation Method
por: Park, Heejun, et al.
Publicado: (2019) -
Preparation and controlled-release studies of a protocatechuic acid-magnesium/aluminum-layered double hydroxide nanocomposite
por: Barahuie, Farahnaz, et al.
Publicado: (2013) -
Input Estimation for Extended-Release Formulations Exemplified with Exenatide
por: Trägårdh, Magnus, et al.
Publicado: (2017)